Pinpoint Therapeutics Inc. — Form D

Pinpoint Therapeutics Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-12. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2019-12-12
• Form: D
• Accession: 0001192482-19-000514
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.0M
• Amount sold: $1.0M
• Minimum investment: $1.0M
• Investors: 1
• Date of first sale: 2019-11-26
• Security types: debt
• Revenue range: No Revenues
• SEC file number: 021-355367

Issuer

• Name: Pinpoint Therapeutics Inc.
• CIK: 0001796645
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 3401 GRAYS FERRY AVENUE, PHILADELPHIA, PA, 19146
• Phone: 610-308-9229

Officers, directors & promoters (2)

More

• CIK 1796645 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search